腹腔内化疗,贝伐珠单抗,卵巢癌的临床试验
总计3453个结果
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)完全的
-
National Cheng-Kung University Hospital完全的输卵管癌 | 腹膜癌 | 卵巢恶性肿瘤(生殖细胞除外)
-
National Cancer Institute (NCI)完全的输卵管癌 | 卵巢透明细胞囊腺癌 | 卵巢子宫内膜样腺癌 | 卵巢浆液性囊腺癌 | IV 期卵巢上皮癌 | 布伦纳瘤 | III期卵巢上皮癌 | 卵巢粘液性囊腺癌 | 卵巢未分化腺癌美国
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center完全的
-
Dana-Farber Cancer InstituteNovartis终止
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)完全的
-
Gynecologic Oncology GroupNational Cancer Institute (NCI); Eli Lilly and Company完全的
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)终止
-
Beihua KongSun Yat-sen University; Huazhong University of Science and Technology; Zhejiang University招聘中
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)完全的
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)Incyte Corporation主动,不招人
-
Grupo Español de Investigación en Cáncer de OvarioRoche Pharma AG终止
-
AbbVie完全的肿瘤学 | 高级别浆液性卵巢癌 | BRCA突变 | BRCA Mutated Breast Cancer
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Bayer终止
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Japanese Gynecologic Oncology GroupKorean Gynecologic Oncology Group招聘中
-
Women's Hospital School Of Medicine Zhejiang University主动,不招人
-
Universitaire Ziekenhuizen KU LeuvenAstraZeneca主动,不招人
-
Chang Gung Memorial HospitalHoffmann-La Roche; Asian Gynecologic Oncology Group; Taiwanese Gynecolgic Oncology Group完全的
-
Sunesis Pharmaceuticals完全的
-
Vanderbilt UniversityNational Cancer Institute (NCI); Celgene Corporation完全的